TD Cowen Maintains DarioHealth(DRIO.US) With Buy Rating, Cuts Target Price to $3
DarioHealth Buy Rating Affirmed: Strategic Growth and Path to Profitability
Press Release: DarioHealth Reports Second Quarter 2024 Financial and Operating Results
Analysts Are Bullish on Top Healthcare Stocks: DarioHealth (DRIO), Moderna (MRNA)
DarioHealth Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA), DarioHealth (DRIO) and Accelerate Diagnostics (AXDX)
Analysts Are Bullish on Top Healthcare Stocks: DarioHealth (DRIO), United Therapeutics (UTHR)
Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Exact Sciences (EXAS) and DarioHealth (DRIO)
DarioHealth (DRIO) Gets a Buy From Stifel Nicolaus
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bioxcel Therapeutics (BTAI) and DarioHealth (DRIO)
LifeSci Capital Keeps Their Buy Rating on DarioHealth (DRIO)
DarioHealth Analyst Ratings
DarioHealth (DRIO) Gets a Buy From LifeSci Capital
Stifel Nicolaus Adjusts DarioHealth Price Target to $6 From $9, Maintains Buy Rating
Stifel Maintains Buy on DarioHealth, Lowers Price Target to $6
DarioHealth Analyst Ratings
LifeSci Capital Reaffirms Their Buy Rating on DarioHealth (DRIO)
LifeSci Capital Remains a Buy on DarioHealth (DRIO)
Craig-Hallum Adjusts DarioHealth's Price Target to $8 From $14, Keeps Buy Rating
Analysts Offer Insights on Healthcare Companies: Societal CDMO (SCTL), Phathom Pharmaceuticals (PHAT) and DarioHealth (DRIO)